Emjard L 5/10mg (14 Tablet / Pack)
Prescription dual-action combination tablet for glycemic management in type 2 diabetes.
Emjard L 5/10mg Tablets are an oral prescription combination medicine engineered to treat adults diagnosed with type 2 diabetes mellitus. It pairs a dipeptidyl peptidase-4 inhibitor with a sodium-glucose co-transporter 2 inhibitor to deliver coordinated blood sugar management. This dual mechanism boosts natural post-meal insulin secretion while simultaneously driving excess glucose out via urinary pathways.
Purpose
Used to lower blood glucose levels and reduce cardiovascular death risks.
Ingredients
Linagliptin 5mg, Empagliflozin 10mg
Warnings
Evaluate baseline kidney function metrics thoroughly before initializing active therapy. Discontinue use immediately if clinical signs of acute pancreatitis manifest. Risk of diabetic ketoacidosis even if blood glucose values appear near normal. Avoid utilizing in patients diagnosed with type 1 diabetes mellitus.
Side Effects
Urinary tract infections Genital mycotic infections Increased frequency of urination Nasopharyngitis or runny nose
Storage Instructions
Store below 30°C in a dry place shielded from light.
| Status | Active |
Related Products
Vesun Sunblock Cream Spf60 (60g)
Venlay Skin Brightening Cream (100g)
Venlay Brightening Face Wash (100ml)
Sylic A Serum (20ml)
Sylic A Face Wash (100ml)
Rucid syrup (120ml)
Rivia Anti Dandruff Shampoo (120ml)
